Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.
PMV mark · valuation
$41.2M
Oct 2026
Priced at
its seed round
Mar 2026
Total raised
$13.7M
Last round
Seed Round
May 2024
Team — not yet on record
No current team members for ParcelBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ParcelBio with a free account
·The complete investor list: 13 names
·Watch ParcelBio: the Monday email on marks, rounds and moves
